BiotechTube
Home/Signatur Biosciences/Dr. Adrian Moody
DA

Dr. Adrian Moody

Chief Development Officer

Signatur Biosciences

Therapeutic Areas

Oncology

Signatur Biosciences Pipeline

DrugIndicationPhase
PCRchitectur-based Prognostic TestBreast Cancer PrognosisDevelopment

Leadership Team at Signatur Biosciences

CD
Celestin de Wergifosse
CEO & Co-founder
PD
Prof. Dame Molly Stevens DBE FRS FREng
Scientific Advisory Board Chair & Co-inventor
DJ
Dr. John Goertz
Scientific Advisor & Co-inventor
View full Signatur Biosciences profile